Search

everythinglearnresearchcommunity

for

Search:↓

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Cold plasma treatment for hair loss was well tolerated and showed improvement in most patients.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Growth factor concentrate therapy helps manage hair loss.

NFIB and STAT5 work together to control specific genetic programs in cells.

The Journal of Cutaneous and Aesthetic Surgery is now included in PubMed.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

AI can personalize exercise routines to improve skin health.

Some improvements in the aesthetics sector have been made, but patient protection is still lacking due to no compulsory register for practitioners and non-prescription dermal fillers.

CHI3L1 and CXCL5 proteins help promote hair growth.

The method effectively measures drug impact on DHT levels in prostate treatments.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Daily intake of 0.5 or 5 mg cobalt ferrite nanoparticles can harm lungs through oxidative and inflammatory stress.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Clofazimine may be effective for treating ashy dermatosis.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.